Michael Wiederhorn
Stock Analyst
(3.73)
# 1,671
Out of 4,648 analysts
132
Total ratings
55.7%
Success rate
5.48%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $364.62 | +9.70% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $155.82 | +7.82% | 8 | Oct 25, 2024 | |
| HUM Humana | Maintains: Outperform | $400 → $280 | $254.08 | +10.20% | 12 | Oct 3, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $127.08 | +14.11% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $42.19 | -5.18% | 3 | Aug 13, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $28 → $34 | $32.61 | +4.26% | 5 | Aug 8, 2024 | |
| TDOC Teladoc Health | Maintains: Outperform | $21 → $17 | $8.70 | +95.51% | 10 | Aug 1, 2024 | |
| CNC Centene | Maintains: Outperform | $110 → $95 | $64.04 | +48.34% | 16 | Jul 29, 2024 | |
| CYH Community Health Systems | Maintains: Outperform | $4.5 → $5 | $4.32 | +15.74% | 10 | Jul 25, 2024 | |
| CI The Cigna Group | Maintains: Outperform | $370 → $400 | $315.49 | +26.79% | 10 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $7.63 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $528.75 | +22.93% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $610 | $558.17 | +9.29% | 13 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $95.51 | +51.82% | 10 | Oct 28, 2022 |
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $364.62
Upside: +9.70%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $155.82
Upside: +7.82%
Humana
Oct 3, 2024
Maintains: Outperform
Price Target: $400 → $280
Current: $254.08
Upside: +10.20%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $127.08
Upside: +14.11%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $42.19
Upside: -5.18%
The Pennant Group
Aug 8, 2024
Maintains: Outperform
Price Target: $28 → $34
Current: $32.61
Upside: +4.26%
Teladoc Health
Aug 1, 2024
Maintains: Outperform
Price Target: $21 → $17
Current: $8.70
Upside: +95.51%
Centene
Jul 29, 2024
Maintains: Outperform
Price Target: $110 → $95
Current: $64.04
Upside: +48.34%
Community Health Systems
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $4.32
Upside: +15.74%
The Cigna Group
May 3, 2024
Maintains: Outperform
Price Target: $370 → $400
Current: $315.49
Upside: +26.79%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $7.63
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $528.75
Upside: +22.93%
Jan 17, 2024
Reiterates: Outperform
Price Target: $610
Current: $558.17
Upside: +9.29%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $95.51
Upside: +51.82%